PSMA-PET superior to MRI in phase II prostate cancer trial
AuntMinnie
JULY 1, 2024
PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. In this phase II clinical trial, the researchers sought to evaluate the approach further.
Let's personalize your content